Evidence map›Paper›PMID 42332066›Full record

ArticleEMBO reports2026

E4BP4 safeguards brown fat mitochondria from obesity-induced fragmentation via ceramide repression.

Fernando Valdivieso-Rivera, Vanessa O Furino, Carlos E Leher, Ariane M Zanesco, Monara Kaélle Cruz, Flavia C Gan, Adriana Leandra Santoro, Lara Regina-Ferreira, Giovanna Leite Santos, Tiago Gonçalves and 7 more

Abstract read
In one paragraph

Article in EMBO reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Fernando Valdivieso-RiveraObesity and Comorbidities Research Center, Universidade Estadual de Campinas (UNICAMP), Campinas, Brazil.ORCID 0000-0001-5044-197X
Vanessa O FurinoObesity and Comorbidities Research Center, Universidade Estadual de Campinas (UNICAMP), Campinas, Brazil.
Carlos E LeherObesity and Comorbidities Research Center, Universidade Estadual de Campinas (UNICAMP), Campinas, Brazil.ORCID 0000-0001-6517-8334
Ariane M ZanescoObesity and Comorbidities Research Center, Universidade Estadual de Campinas (UNICAMP), Campinas, Brazil.ORCID 0000-0003-4842-1421
Monara Kaélle CruzLaboratory of Immunometabolism, Department of Genetics, Evolution, Microbiology and Immunology-Institute of Biology, Universidade Estadual de Campinas (UNICAMP), Campinas, Brazil.
Flavia C GanObesity and Comorbidities Research Center, Universidade Estadual de Campinas (UNICAMP), Campinas, Brazil.
Adriana Leandra SantoroObesity and Comorbidities Research Center, Universidade Estadual de Campinas (UNICAMP), Campinas, Brazil.ORCID 0000-0002-7208-5037
Lara Regina-FerreiraObesity and Comorbidities Research Center, Universidade Estadual de Campinas (UNICAMP), Campinas, Brazil.
Giovanna Leite SantosDepartment of Pathology, Universidade Estadual de Campinas (UNICAMP), Campinas, Brazil.
Tiago GonçalvesCenter for Research in Inflammatory Diseases (CRID), Ribeirão Preto Medical School, Universidade de São Paulo (FMRP-USP), Ribeirão Preto, Brazil.
Luiz Osório LeiriaCenter for Research in Inflammatory Diseases (CRID), Ribeirão Preto Medical School, Universidade de São Paulo (FMRP-USP), Ribeirão Preto, Brazil.ORCID 0000-0001-9483-3705
Pedro M Moraes-VieiraObesity and Comorbidities Research Center, Universidade Estadual de Campinas (UNICAMP), Campinas, Brazil.
Roger Frigério CastilhoDepartment of Pathology, Universidade Estadual de Campinas (UNICAMP), Campinas, Brazil.ORCID 0000-0003-2338-8717
Shingo KajimuraDivision of Endocrinology, Diabetes and Metabolism, Beth Israel Deaconess Medical Center and Harvard Medical School, and Howard Hughes Medical Institute, Boston, MA, USA.ORCID 0000-0003-0672-5910
Marcelo A MoriObesity and Comorbidities Research Center, Universidade Estadual de Campinas (UNICAMP), Campinas, Brazil.ORCID 0000-0001-7112-5263
Licio A VellosoObesity and Comorbidities Research Center, Universidade Estadual de Campinas (UNICAMP), Campinas, Brazil.ORCID 0000-0002-4806-7218
Carlos H SpontonObesity and Comorbidities Research Center, Universidade Estadual de Campinas (UNICAMP), Campinas, Brazil. csponton@usp.br.ORCID 0000-0003-4284-8176

Funding

Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) 2019/15025-5,2020/14725-0,2020/06057-8,2021/08354-2,2013/07607-8,2021/12964-0
6 · The paper itself

Abstract

Brown adipose tissue (BAT) counteracts obesity-related metabolic dysfunction through both thermogenic and non-thermogenic means. However, substantial evidence indicates that obesity negatively affects BAT mitochondrial morphology and oxidative capacity, impairing systemic energy homeostasis. Motivated by this apparent contradiction, we investigate the relationship between obesity and mitochondrial dynamics, as the underlying mechanisms remain incompletely understood. Here, we identify E4BP4 as a transcriptional repressor that prevents obesity-induced mitochondrial fragmentation and oxidative dysfunction by inhibiting ceramide synthesis in brown fat. Specifically, E4BP4 interacts with PRDM16 to repress Cers6 mRNA expression and consequently reduces C16:0 ceramide levels by binding to a 65 kb upstream enhancer region of the Cers6 gene. Notably, the preservation of mitochondrial integrity in BAT by E4BP4 gain-of-function improves systemic glucose homeostasis, independent of weight loss. Collectively, our findings establish E4BP4 as a molecular safeguard against obesity-induced mitochondrial fragmentation and oxidative dysfunction, primarily by suppressing ceramide synthesis in brown fat.

Indexed as

Adipose Tissue, BrownCeramidesMitochondriaObesityAnimalsDNA-Binding ProteinsGene Expression RegulationHumansMiceProtein BindingSphingosine N-AcyltransferaseTranscription FactorsCeramidesDNA-Binding ProteinsPrdm16 protein, mouseSphingosine N-AcyltransferaseTranscription Factors

Identifiers

PMID42332066
PMCPMC13458363

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.